Parkinson's disease is a disorder of the brain that leads to shaking (tremors) and difficulty with movement and coordination. In the US, approximately 1 million people suffer from Parkinson's disease, and about 50,000 new cases are reported annually. These figures are expected to increase as the population ages; it is estimated that today the annual financial burden of Parkinson's disease in the US is $23 billion, and by 2040, the cost will exceed $50 billion annually.

There are treatments that help with the symptoms related to motor skills at the earlier stages of the disease, but there aren't any treatments that stop the progression of the disease or that treat the non-motor symptoms. Given that people with Parkinson's tend to live a relatively long time but with disability, Parkinson's disease lends itself to taking advantage of innovations in telemedicine, particularly as the disease becomes more disabling.

Donate

 
Up   Down
Donate to The Feinstein Institute
for Medical Research
 Visit The Feinstein Institute Online